Whole-tumour evaluation with MRI and radiomics features to predict the efficacy of S-1 for adjuvant chemotherapy in postoperative pancreatic cancer patients: a pilot study
Open accessThe DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
Abstract
Background: Multiple guidelines for pancreatic ductal adenocarcinoma (PDAC) suggest that all stages of patients need to receive postoperative adjuvant chemotherapy. S-1 is a recently emerged oral antitumour agent recommended by the guidelines. However, which population would benefit from S-1 needs to be determined, and predictors of chemotherapy response are needed for personalized precision medicine. This pilot study aimed to initially identify whether whole-tumour evaluation with MRI and radiomics features could be used for predicting the efficacy of S-1 and to find potential predictors of the efficacy of S-1 as evidence to assist personalized precision treatment. Methods: Forty-six patients with PDAC (31 in the primary cohort and 15 in the validation cohort) who underwent curative resection and subsequently adjuvant chemotherapy with S-1 were included. Pre-operative abdominal contrast-enhanced MRI was performed, and radiomics features of the whole PDAC were extracted from the primary cohort. After univariable analysis and radiomics features selection, a multivariable Cox regression model for survival analysis was subsequently used to select statistically significant factors associated with postoperative disease-free survival (DFS). Predictive capacities of the factors were tested on the validation cohort by using Kaplan–Meier method. Results: Multivariable Cox regression analysis identified the probability of T 1 WI_NGTDM_Strength and tumour location as independent predictors of the efficacy of S-1 for adjuvant chemotherapy of PDAC (p = 0.005 and 0.013) in the primary cohort, with hazard ratios (HRs) of 0.289 and 0.293, respectively. Further survival analysis showed that patients in the low-T 1 WI_NGTDM_Strength group had shorter DFS (median = 5.1 m) than those in the high-T 1 WI_NGTDM_Strength group (median = 13.0 m) (p = 0.006), and patients with PDAC on the pancreatic head exhibited shorter DFS (median = 7.0 m) than patients with tumours in other locations (median = 20.0 m) (p = 0.016). In the validation cohort, the difference in DFS between patients with low-T 1 WI_NGTDM_Strength and high-T 1 WI_NGTDM_Strength and the difference between patients with PDAC on the pancreatic head and that in other locations were approved, with marginally significant (p = 0.073 and 0.050), respectively. Conclusions: Whole-tumour radiomics feature of T 1 WI_NGTDM_Strength and tumour location were potential predictors of the efficacy of S-1 and for the precision selection of S-1 as adjuvant chemotherapy regimen for PDAC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Radiomics: Images Are More than Pictures, They Are Data
Gillies, R. J., Kinahan, P. E., & Hricak, H. (2016) · Radiology · doi:10.1148/radiol.2015151169 · Cited by 8,421
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Gerlinger, M., Rowan, A. J., Horswell, S., Larkin, J., Endesfelder, D., Gronroos, E., Martinez, P., Matthews, N., Stewart, A., Tarpey, P., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113205 · Cited by 7,774 · cited 1×
“From the results of our study, NGTDM_Strength from T1WI was independently related to the therapy response of PDAC, supporting that radiomics features could potentially reflect the biological information of tumours, including the intratumoural heterogeneity associated with the response to treatment and survival [14, 34…”
ResultComputational Radiomics System to Decode the Radiographic Phenotype
(2017) · doi:10.1158/0008-5472.can-17-0339 · Cited by 6,593
Oettle, H., Post, S., Neuhaus, P., Gellert, K., Langrehr, J., Ridwelski, K., Schramm, H., Fahlke, J., Zuelke, C., Burkart, C., et al. (2007) · JAMA · doi:10.1001/jama.297.3.267 · Cited by 2,419
Applications and limitations of radiomics
Yip, S. S. F., & Aerts, H. J. W. L. (2016) · Physics in Medicine and Biology · doi:10.1088/0031-9155/61/13/r150 · Cited by 1,210
Uesaka, K., Boku, N., Fukutomi, A., Okamura, Y., Konishi, M., Matsumoto, I., Kaneoka, Y., Shimizu, Y., Nakamori, S., Sakamoto, H., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30583-9 · Cited by 1,115
Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology
Tempero, M. A., Malafa, M. P., Al-Hawary, M., Asbun, H., Bain, A., Behrman, S. W., Benson, A. B., Binder, E., Cardin, D. B., Cha, C., et al. (2017) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2017.0131 · Cited by 1,020
Shirasaka, T., Shimamato, Y., Ohshimo, H., Yamaguchi, M., Kato, T., Yonekura, K., & Fukushima, M. (1996) · Anti-Cancer Drugs · doi:10.1097/00001813-199607000-00010 · Cited by 820
CT Texture Analysis: Definitions, Applications, Biologic Correlates, and Challenges
Lubner, M. G., Smith, A. D., Sandrasegaran, K., Sahani, D. V., & Pickhardt, P. J. (2017) · RadioGraphics · doi:10.1148/rg.2017170056 · Cited by 773
Cited by
Preuss, K., Thach, N., Liang, X., Baine, M., Chen, J., Zhang, C., Du, H., Yu, H., Lin, C., Hollingsworth, M. A., et al. (2022) · Cancers · doi:10.3390/cancers14071654 · Cited by 69
“[119] MRI Pyradiomics Efficacy of S-1 (oral antitumor agent) Semiautomatic (2, a generic automatic segmentation algorithm based on a 3D domain using a prototype software, Radiomics, Siemens) 31 + 15 110 T1WI_NGTDM_Strength and tumor location are independent predictors of the efficacy of S-1 in the training cohort (p =…”
MethodJiang, J., Chao, W.-L., Culp, S., & Krishna, S. G. (2023) · Cancers · doi:10.3390/cancers15092410 · Cited by 38
Application of Artificial Intelligence in the Management of Pancreatic Cystic Lesions
Rangwani, S. M., Ardeshna, D. R., Rodgers, B., Melnychuk, J., Turner, R. C., Culp, S., Chao, W., & Krishna, S. G. (2022) · Biomimetics · doi:10.3390/biomimetics7020079 · Cited by 21
Malagi, A., Shivaji, S., Kandasamy, D., Sharma, R., Garg, P. K., Gupta, S. D., Gamanagatti, S. R., & Mehndiratta, A. (2023) · Bioengineering · doi:10.3390/bioengineering10010083 · Cited by 16
Chen, Y., Qi, Y., Li, T., Lin, A., Ni, Y., Pu, R., & Sun, B. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1393841 · Cited by 15
Metadata
- Authors
- Liang, L., Ding, Y., Yu, Y., Liu, K., Rao, S., Ge, Y., & Zeng, M.
- Affiliations
- Shanghai Medical College of Fudan University (CN)
- Corresponding author
- Zeng, Mengsu
- Venue
- BMC Medical Imaging
- Published
- 2021-04-26
- Volume
- 21
- Issue
- 1
- Pages
- 75-75
- ISSN
- 1471-2342 (ISSN-L)
- PMC
- PMC8077911
- OpenAlex
- W3158457961
- Cited by
- 13
- References
- 44
- Citations by year
- 2025: 2 · 2024: 2 · 2023: 5 · 2022: 3
- FWCI
- 1.32
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- BMC Medical Imaging (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Special Program of Clinical Research in Health Industry, Shanghai Municipal Health Commission (201840343)
- Topics
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiomics and Machine Learning in Medical Imaging
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › MRI in cancer diagnosis
- Keywords
- pancreatic ductal adenocarcinoma, S-1, adjuvant chemotherapy, radiomics, treatment response prediction, disease-free survival, T1-weighted imaging, tumor location, pancreatic head, precision medicine, prognostic factors, curative resection, contrast-enhanced MRI, tumor heterogeneity
- MeSH terms
- Analysis of Variance, Antimetabolites, Antineoplastic, Contrast Media, Drug Administration Schedule, Drug Combinations, Female, Tegafur, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Oxonic Acid, Pancreatic Neoplasms, Pilot Projects, Postoperative Care, Retrospective Studies, Survival Analysis, Treatment Outcome, Chemotherapy, Adjuvant, Disease-Free Survival, Carcinoma, Pancreatic Ductal, Precision Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Whole-tumour evaluation with MRI and radiomics features to predict the efficacy of S-1 for adjuvant chemotherapy in postoperative pancreatic cancer patients: a pilot study. https://app.cochat.ai/papers/10.1186/s12880-021-00605-4
- The paper
- Liang, L., Ding, Y., Yu, Y., Liu, K., Rao, S., Ge, Y., & Zeng, M. (2021). Whole-tumour evaluation with MRI and radiomics features to predict the efficacy of S-1 for adjuvant chemotherapy in postoperative pancreatic cancer patients: a pilot study. BMC Medical Imaging. https://doi.org/10.1186/s12880-021-00605-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.